FDAnews
www.fdanews.com/articles/131348-glaxo-cuts-cervarix-price-by-30-percent-in-canada

Glaxo Cuts Cervarix Price by 30 Percent in Canada

October 25, 2010
GlaxoSmithKline has cut the price of its cervical cancer vaccine Cervarix by 30 percent in Canada in a bid to encourage greater uptake of the product.
ForexPros